临床药师参与多学科联合诊疗对COPD患者的疗效研究

打开文本图片集

摘 要 目的：探索临床药师与多学科协作开展对慢性阻塞性肺疾病（COPD）患者的治疗效果。方法：将178例COPD患者随机分为干预组（n=89）和对照组（n=89），对照组采用常规治疗，干预组在此基础上采用医师、护士、药师多学科联合诊疗，观察两组患者干预效果。结果：干预后，两组Wmax、GQOLI-74评分、SAS评分、SDS评分变化显著，且干预组明显优于对照组（P

关键词 多学科联合诊疗 COPD 临床药师

中图分类号：R563 文献标志码：A 文章编号：1006-1533（2023）07-0069-04

引用本文 叶进， 周琦， 朱卫锋， 等. 临床药师参与多学科联合诊疗对COPD患者的疗效研究[J]. 上海医药， 2023， 44（7）： 69-72.

基金项目：浦东新区老年医院科研项目（2021LNYNKT-A02）

Study on the efficacy of clinical pharmacists’ participation in multidisciplinary joint treatment for COPD patients

YE Jin1， ZHOU Qi2， ZHU Weifeng3， YU Teng3

（1. Department of Pharmacy； 2. Medical Department； 3. Department of Respiratory Medicine， Shanghai Pudong Geriatric Hospital， Shanghai 201314， China）

ABSTRACT Objective： To explore the effectiveness of clinical pharmacist and multidisciplinary collaboration in the treatment of patients with chronic obstructive pulmonary disease （COPD）. Methods： One hundred and seventy-eight COPD patients were randomly divided into an intervention group （n=89） and a control group （n=89）. The control group was conventionally treated， and the intervention group was treated with the multidisciplinary collaboration of physicians， nurses and pharmacists besides the conventional treatment， and the intervention effects were observed in the two groups. Results： After the intervention， the changes in Wmax， GQOLI-74 score， SAS score and SDS score were significant in both groups and were significantly better in the intervention group than the control group （P

KEY WORDS multidisciplinary joint diagnosis and treatment； chronic obstructive pulmonary disease； clinical pharmacist

慢性阻塞性肺疾病（chronic obstructive pulmonary disease， COPD）是一种常见的、可预防和治疗的慢性气道疾病，其特征是持续存在的气流受限和相应的呼吸系统症状，通常与显著暴露于有害颗粒或气体相关[1]。（剩余5330字）